Christopher Timmermann is a neuroscientist and psychologist and co-director of the UCL Centre for Consciousness Science, where he focuses on understanding the mind in non-ordinary states of consciousness. After obtaining his PhD in neuropsychopharmacology, Christopher led the DMT Research Group at Imperial College London, which pioneered the first brain imaging studies of short-acting psychedelics. His work has focused on the neuroscience, psychiatry, and psychology of meditation and psychedelics to inform consciousness and mental health research. His research has been published in high-impact journals and covered by outlets such as The New York Times, the BBC, The Guardian, and Wired. He is also the co-founder and president of a research and educational non-profit organisation in Latin America, the ECOH Foundation for the Study of Human Consciousness.